To bring technology to patients to reduce catheter derived sepsis, save lives and reduce healthcare costs.
May 13, 2017
Great Lakes Pharmaceuticals, Inc. officially rebranded as Prevacept Infection Control, Inc. on May 13, 2017, in conjunction with rebranding of B-Lock Solution as PrevaCept Lock Solution.
August 2, 2017
Prevacept Infection Control, Inc. filed for CE-Mark for PrevaCept Lock Solution on August 2, 2017.
September 12, 2017
Prevacept closed the second tranche of an institutional financing on September 12, 2017